A Phase IIIB/IV Study to Compare the Efficacy of Vancomycin Therapy to Extended Duration of Fidaxomicin Therapy in the Clinical Cure of Clostridium Difficile Infection (CDI) in an Older Population
Clinical trial NCT02254967 · COMPLETED
Trial details
- NCT number
- NCT02254967
- Sponsor
- Astellas Pharma Europe Ltd.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2014-11-06
- Primary completion
- 2016-03-27
- Enrollment
- 364
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.